Alliance Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner
Published April 3, 2017
Washington, D.C., April 3, 2017– Alliance for Aging Research (Alliance) President and CEO Susan Peschin, MHS, has issued a statement in support of the nomination of Dr. Scott Gottlieb to be commissioner of the U.S. Food and Drug Administration (FDA).
The Alliance for Aging Research supports the nomination of Dr. Scott Gottlieb to be the next FDA commissioner. The FDA requires a strong leader who has deep knowledge of the regulatory process and understands how it affects patient access to new medical products. We believe that Dr. Gottlieb’s expertise as a former regulator and physician will serve the FDA well and benefit the health of the American public.
The Alliance is pleased that the Senate Health, Education, Labor, and Pensions Committee will consider Dr. Gottlieb’s nomination later this week. We urge swift action after this hearing to confirm his nomination.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application in order to vastly improve the universal human experience of aging and health. The Alliance was founded in 1986 in Washington, D.C., and has since become a valued advocacy organization and a respected influential voice with policymakers. Visit www.agingresearch.org for more information.